Buffer solution for electroporation and a method comprising the use of the same
View Patent ↗The invention relates to a buffer solution for suspending animal or human cells and for dissolving biologically active molecules in order to introduce biologically active molecules into cells using an electric current. The inventive buffer solution has a buffering capacity of at least 20 mmol −1 ×pH −1 and an ionic strength of at least 200 mmol×1 −1 during a change to the pH value from pH 7 to pH 8 and at a temperature of 25° C. The use of a buffer solution of this type allows biologically active molecules to be introduced into animal and human cells with a high degree of transfection efficiency and at the same time a low cell mortality. Different cell types, in particular dormant and actively dividing cells of low activity, can be successfully transfected in the buffer solution.
1. A buffer solution for suspending animal or human cells and/or for dissolving biologically active molecules in order to introduce said biologically active molecules into the cells using electric current, the buffer solution (1) having a buffer capacity of at least 20 mmol×1 −1 pH −1 and an ionic strength of at least 200 mmol×1 −1 at a change in the pH from about pH 7 to about pH 8 and at a temperature of 25° C., and (2) comprising a lower concentration of potassium ions (K + ) between 2 to 6 mmol×1 −1 K + , and a concentration of sodium ions (Na + ) between 100 to 150 mmol×1 −1 Na + , and (3) comprising a concentration of magnesium ions (Mg 2+ ) of at least 10 mmol×1 −1 magnesium ions (Mg 2+ ).
2. The buffer solution of claim 1 having a buffer capacity between 22 and 80 mmol×1 −1 ×pH −1 .
3. The buffer solution of claim 1 having a buffer capacity between 40 and 70 mmol×1 −1 ×pH −1 .
4. The buffer solution according to of claim 1 , having an ionic strength between 200 and 500 mmol×1 −1 .
5. The buffer solution of claim 1 having an ionic strength between 250 and 400 mmol×1 −1 .
6. The buffer solution of claim 1 , wherein the concentration of magnesium ions is about 15 to 20 mmol×1 −1 magnesium ions.
7. The buffer solution of claim 1 , wherein said magnesium ions are provided by magnesium chloride (MgCl 2 ) and/or magnesium sulphate (MgSO 4 ).
8. The buffer solution of claim 1 comprising HEPES and/or Na 2 HPO 4 /NaH 2 PO 4 and/or Tris/HCl and/or K 2 HPO 4 /KH 2 PO 4 .
9. The buffer solution of claim 1 , wherein said sodium ions are provided by sodium chloride, sodium succinate, and/or sodium lactobionate, and further comprising mannitol, glucose, and/or peptides.
10. A buffer solution for suspending animal or human cells and/or for dissolving biologically active molecules in order to introduce said biologically active molecules into the cells using electric current, the buffer solution (1) having a buffer capacity of at least 20 mmol×1 −1 ×pH −1 and an ionic strength of at least 200 mmol×1 −1 at a change in the pH from about pH 7 to about pH 8 and at a temperature of 25° C., and (2) comprising 4-6 mM KCl, 10-20 mM MgCl 2 and 120-160 mM Na 2 HPO 4 /NaH 2 PO 4 (at a pH of about 7.2).
11. A buffer solution for suspending animal or human cells and/or for dissolving biologically active molecules in order to introduce said biologically active molecules into the cells using electric current, the buffer solution (1) having a buffer capacity of at least 20 mmol×pH −1 and an ionic strength of at least 200 mmol×1 −1 at a change in the pH from about pH 7 to about pH 8 and at a temperature of 25° C., and (2) comprising 4-6 mM KCl, 10-20 mM MgCl 2 , 5-25 mM HEPES and 120-160 mM Na 2 HPO 4 /NaH 2 PO 4 (at a pH of about 7.2).
12. A buffer solution for suspending animal or human cells and/or for dissolving biologically active molecules in order to introduce said biologically active molecules into the cells using electric current, the buffer solution (1) having a buffer capacity of at least 20 mmol×1 −1 ×pH −1 and an ionic strength of at least 200 mmol×1 −1 at a change in the pH from about pH 7 to about pH 8 and at a temperature of 25° C., and (2) comprising 4-6 mM KCl, 10-20 mM MgCl 2 , 50-160 mM Na 2 HPO 4 /NaH 2 PO 4 (at a pH of about 7.2), and one or more components selected from the group consisting of 5-100 mM sodium lactobionate, 5-100 mM mannitol, 5-100 mM sodium succinate, and 5-100 mM sodium chloride.
13. A buffer solution for suspending animal or human cells and/or for dissolving biologically active molecules in order to introduce said biologically active molecules into the cells using electric current, the buffer solution (1) having a buffer capacity of at least 20 mmol×1 −1 ×pH −1 and an ionic strength of at least 200 mmol×1 −1 at a change in the pH from about pH 7 to about pH 8 and at a temperature of 25° C., and (2) comprising 4-6 mM KCl, 10-20 mM MgCl 2 , 5-25 mM HEPES, 50-160 mM Na 2 HPO 4 /NaH 2 PO 4 (at a pH of about 7.2), and one or more components selected from the group consisting of 5-100 mM sodium lactobionate, 5-100 mM mannitol, 5-100 mM sodium succinate, and 5-100 mM sodium chloride.
14. A buffer solution for suspending animal or human cells and/or for dissolving biologically active molecules in order to introduce said biologically active molecules into the cells using electric current, the buffer solution (1) having a buffer capacity of at least 20 mmol×1 −1 ×pH −1 and an ionic strength of at least 200 mmol×1 −1 at a change in the pH from about pH 7 to about pH 8 and at a temperature of 25° C., and (2) comprising 4-6 mM KCl, 10-20 mM MgCl 2 , 80-100 mM NaCl, 8-12 mM glucose, 0.3-0.5 mM Ca(NO 3 ) 2 , 20-25 mM HEPES, and one or more components selected from the group consisting of 50-100 mM tris/HCl, and 30-50 mM Na 2 HPO 4 /NaH 2 PO 4 (at a pH of about 7.2).